drugset / Trial / NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Non-randomizedSequentialOpen-labelTreatment
Summary
An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.
Timeline
- Start
- 2020-02-28
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P-PSMA-101 CAR-T cells | Cell therapy | — | Intravenous |
| Background | Rimiducid | Other / unclassified | — | — |